
Mustang Bio
(NASDAQ) MBIO
Mustang Bio Financials at a Glance
Market Cap
$5.33M
Revenue (TTM)
$0.00
Net Income (TTM)
-$2.72M
EPS (TTM)
-$0.48
P/E Ratio
-1.46
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$0.63
Volume
200
Open
$0.66
Price
$0.63
Volume
200
Open
$0.66
Previous Close
$0.63
Daily Range
$0.63 - $0.66
52-Week Range
$0.53 - $7.00
Estimated Earnings Date
Aug 18, 2026
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$0.63
Volume
200
Open
$0.66
Previous Close
$0.63
Daily Range
$0.63 - $0.66
52-Week Range
$0.53 - $7.00
Estimated Earnings Date
Aug 18, 2026
MBIO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Mustang Bio
Industry
Biotechnology
Sector
Health CareEmployees
4
CEO
Manuel Litchman, MD
Website
www.mustangbio.comHeadquarters
Waltham, MA 02453, US
MBIO Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-35.38%
Return on Capital
-25.52%
Return on Assets
-16.42%
Earnings Yield
-68.49%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.33M
Shares Outstanding
7.58M
Volume
200
Avg. Volume
132.20K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$3.24M
EBITDA
-$2.72M
Operating Cash Flow
-$4.88M
Capital Expenditure
$0.00
Free Cash Flow
-$4.88M
Cash & ST Invst.
$16.26M
Total Debt
$0.00
Mustang Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$5.33M
N/A
Market Cap/Employee
$1.33M
N/A
Employees
4
N/A
Net Income
-$955.00K
-524.2%
EBITDA
-$955.00K
-752.7%
Quarterly Fundamentals
Total Cash
$16.26M
+14.2%
Total Debt
$0.00
N/A
Accounts Receivable
$217.00K
-53.5%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-16.42%
N/A
Return on Invested Capital
-37.01%
N/A
Free Cash Flow
-$1.01M
+27.4%
Operating Cash Flow
-$1.01M
+27.4%

